BioPharma EHS Forum, September 16 – 17 2015

Posted by: biopharmaehsforum | March 31, 2015

Here is the agenda of the recent Sep 16-17, 2015 BioPharma EHS Forum. Information about next year’s forum soon to come.

Wednesday, September 16

Keynote: NIOSH Hazardous Drug Alert – New Format, Rationale for Monoclonal Antibodies Decision, State Activities – A presentation on the 2014 alert on hazardous drug exposures in health care settings. The BioPharma EHS Forum commented during the 2007, 2009, and 2013 updates of the NIOSH “List of Antineoplastic and Other Hazardous Drugs in Heathcare Settings.” NIOSH’s rationale for the changes made and state-level activity use of the list in regulatory settings will be of interest to attendees.

Emerging Issues in BioPharma EHS, Product Stewardship – Emerging trends in Product Stewardship and Environmental Safety and Health for BioPharma companies.

Management Systems: Maximizing the Value Proposition and Lessons from the Field – Experience on management systems and their effectiveness. The lessons learned should be particularly valuable as part of this interactive session.

Member Panel: Lessons Learned in the Evolution of Safety Cultures – Members appreciate hearing about the experiences of their colleagues. Different companies will share the evolution of their safety cultures.

Managing Change: How to Navigate Different Company Governance Structures, Leadership Styles, and EHS Cultures – Considerable experiences with (1) how to focus on what is important; (2) how to leverage resources; (3) how to best present yourself; (4) how to meet your customer’s expectations; and (5) how change can come through many fronts.

EHS Initiatives Roundtable – One person from each company will share 2015 EHS initiatives, or those underway or recently completed that may be of interest to other members.

Day one will adjourn at 5:15 p.m.; the No Host Group dinner will begin at 6:30 p.m. at the Colonial Inn after a walk around historic Concord.

The Continuum of Enforcement: From Compliance to Criminal Enforcement – How an inspection goes from civil to criminal, from his informed perspective. Always good to hear about how to avoid criminal enforcement!

Green Chemistry: Case Studies in Safety Chemistries – Case studies related to the use of safer chemistry.

Member Panel: Emerging Topics in Biosafety – Emerging topics in biosafety that are of interest to members.

BioPharma EHS Forum Member Sustainability Initiatives and Lessons Learned – This popular session is back, as requested by members for bi-annual discussion. Members are invited to share their ongoing initiatives and lessons learned.

2016 Meeting Planning – Do we want the focus of next meeting to be biologics, pharmaceuticals or biopharmaceuticals? Moving back to West Coast? Host volunteers? Planning Committee members?

Please let me know if you have any questions.

Thank you,

Elizabeth Treanor

Phylmar Sacramento Office: P. O. Box 660912

Sacramento, California 95866; +1.916.486.4415